Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model

Overexpression of Cell Surface Cytokeratin 8 in Multidrug-Resistant MCF-7/MX Cells Enhances Cell Adhesion to the Extracellular Matrix

(2015) Fang Liu et al.   NEOPLASIA

Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model

(2013) Qiqi Zhu et al.   Cancer Cell International

Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats

(2012) Zhongya Chen et al.   International Journal of Nanomedicine

Enhanced Antitumor Efficacy and Reduced Systemic Toxicity of Sulfatide-Containing Nanoliposomal Doxorubicin in a Xenograft Model of Colorectal Cancer

(2012) Jia Lin et al.   PLoS One

Antiangiogenic Activity of Sterically Stabilized Liposomes Containing Paclitaxel (SSL-PTX): In Vitro and In Vivo

(2010) Yue Huang et al.   AAPS PHARMSCITECH

Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles

(2010) Takemi Tanaka et al.   CANCER RESEARCH

Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells

(2010) Hilary Shmeeda et al.   JOURNAL OF CONTROLLED RELEASE

CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics

(2010) Long Xu et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase

(2010) JingXia Cui et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody

(2009) T. A. ElBayoumi et al.   CLINICAL CANCER RESEARCH

Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity

(2009) Suk Hyun Jung et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin

(2009) XueMing Li et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system

(2009) C. Foti et al.   MOLECULAR CANCER THERAPEUTICS

Drug uptake in a rodent sarcoma model after intravenous injection or isolated lung perfusion of free/liposomal doxorubicin

(2009) C. Cheng et al.   Interactive Cardiovascular and Thoracic Surgery

Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations

(2008) Guangli Wei et al.   BIOMEDICAL CHROMATOGRAPHY

Tumor Escape from Endogenous, Extracellular Matrix-Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors

(2008) N. T. Fernando et al.   CLINICAL CANCER RESEARCH

The effect of doxorubicin on rats that received toxic and carcinogenic benzo(a)pyrene.

(2008) Didem Cosan et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

A review of stimuli-responsive nanocarriers for drug and gene delivery

(2008) Srinivas Ganta et al.   JOURNAL OF CONTROLLED RELEASE

Targeted delivery of doxorubicin via estrone-appended liposomes

(2008) Shivani Rai et al.   JOURNAL OF DRUG TARGETING

Emerging nanopharmaceuticals

(2008) Willie E. Bawarski et al.   Nanomedicine-Nanotechnology Biology and Medicine

Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein

(2008) Fa Yun Zhang et al.   PHARMACEUTICAL RESEARCH

New frontiers in nanotechnology for cancer treatment

(2008) Frank Alexis et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS